Biostatistics for Clinical Research: A Practical Guide
2026-05-01 • 9 min
Quick Answer
Biostatistics in clinical research means selecting valid endpoints, planning sample size correctly, and matching tests to your study design. When methods align with research questions and assumptions, results become reliable, interpretable, and publication-ready for journals, ethics boards, and evidence-based decision making.
Why Biostatistics Is Foundational
Clinical research depends on transparent, reproducible evidence. Biostatistics translates medical questions into testable hypotheses, identifies measurement strategy, and quantifies uncertainty. Without rigorous design and analysis, even large studies can produce misleading conclusions.
Design Before Analysis
Strong projects define primary outcomes, inclusion criteria, confounders, and effect size targets before data collection. This prevents post-hoc bias and protects inferential validity. Protocol-level decisions should document statistical assumptions and fallback methods for non-normal or incomplete data.
Interpretation and Reporting
Report effect estimates with confidence intervals, clinical context, and model assumptions. Avoid over-reliance on p-values alone. Transparent reporting should include missing-data handling, sensitivity analyses, and practical implications for clinicians and policy stakeholders.
Frequently Asked Questions
What is the first statistical step in a clinical study?
Start by defining a primary endpoint and target effect size, then select an analysis model aligned with study design and outcome type.
Why are confidence intervals important?
Confidence intervals communicate estimate precision and likely effect ranges, offering more context than significance testing alone.